Andrew Cunha, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 39201 State St, Fremont, CA 94538 Phone: 510-791-5521 |
Naimishkumar Bharatkumar Sheth, MSPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 3575 Beacon Ave, Fremont, CA 94538 Phone: 510-794-9672 |
Arleen Joyce Ballin, P.T. Physical Therapist - Orthopedic Medicare: Not Enrolled in Medicare Practice Location: 39400 Paseo Padre Pkwy, Fremont, CA 94538 Phone: 510-248-3200 |
Mrs. Ragini Satish Herekar, P.T. Physical Therapist Medicare: May Accept Medicare Assignments Practice Location: 39180 Farwell Dr,, Fremont, CA 94538 Phone: 510-585-2545 Fax: 866-484-5954 |
News Archive
Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (VelcadeĀ®).
Poor kidney function prior to heart surgery can lead to worse outcomes, higher surgical costs, and a longer hospital stay, according to an article posted online today by The Annals of Thoracic Surgery.
When surgery and medication don't help people with epilepsy, electrical stimulation of the brain has been a treatment of last resort.
Inflammatory bowel diseases (IBDs), including Crohn disease and ulcerative colitis, are hard to completely cure. Globally, IBDs affect more than 4 million people, today. However, Professor Soichi Tanabe (Graduate School of Biosphere Science, Hiroshima University) and his collaborators have demonstrated that 10-hydroxy-cis-12-octadecenoic acid (HYA), a gut microbial metabolite of linoleic acid, has a suppressive effect on intestinal inflammation.
› Verified 5 days ago